PMA · Approved
Recalled · Class II · 2015Gelseal TM Triaxial Vascular Graft
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Carbomedics, Inc. · MAL Graft, Vascular, Synthetic/Biologic Composite
Approved on Jan 11, 1993 through premarket approval, which rests on the device’s own clinical evidence after a 1,239-day review. 2 later devices descend from it. It has been recalled 2 times.
- Decided
- Jan 11, 1993
- Review
- 1,239 days
- Class
- Class II
- Product code
- MAL
- Recalls
- 2
2 later devices descend from it, 1 citing it directly.
- This deviceP890045 Gelseal TM Triaxial Vascular GraftCarbomedics, Inc. · 1993
- Descendant · cites it directly · 1 of its ownK162803 Gelseal Vascular Grafts, Gelsoft Vascular Grafts, Gelsoft Plus…Vascutek, Ltd. · 2017
- Descendant · 2 generations on · 0 of its ownK241070 Gelsoft™ Plus Vascular ProsthesesVascutek, Ltd. · 2024 · Recalled
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| 0 (this device) | P890045 | Gelseal TM Triaxial Vascular Graft | Carbomedics, Inc. | 1993 | — |
| +1 | K162803 | Gelseal Vascular Grafts, Gelsoft Vascular Grafts, Gelsoft Plus Vascular Grafts | Vascutek, Ltd. | 2017 | — |
| +2 | K241070 | Gelsoft™ Plus Vascular Prostheses | Vascutek, Ltd. | 2024 | 1 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2017 | 1 | 0 |
| 2024 | 1 | 0 |
Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MAL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
Does it have a predicate?
PMA decisions do not claim a predicate device.
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K162803 | Gelseal Vascular Grafts, Gelsoft Vascular Grafts, Gelsoft Plus Vascular Grafts | 2017 | 1 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| May 15, 2015 | Class II | Z-1912-2015 | Error in labeling | Product was labeled as a 30cm graft, when in fact the graft in the box was a 15cm graft. |
| May 15, 2015 | Class II | Z-1913-2015 | Error in labeling | Product was labeled as a 30cm graft, when in fact the graft in the box was a 15cm graft. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Of its descendants, K162803 (Vascutek, Ltd., 2017) has gone furthest, with 1 descendant of its own.
How does its category compare?
All MAL devicesMAL Graft, Vascular, Synthetic/Biologic Composite: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MAL
1in 2012
2026 to Oct 25, outlined.
Median 510(k) review, days · MAL
Too few MAL 510(k)s in any year since 2007 to give a median.
Recalls per year · MAL
1in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MAL
27in 2025
MAUDE reports naming product code MAL, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 14 |
| 2008 | 0 | — | 0 | 12 |
| 2009 | 0 | — | 0 | 5 |
| 2010 | 1 | — | 3 | 7 |
| 2011 | 1 | — | 0 | 13 |
| 2012 | 1 | — | 0 | 14 |
| 2013 | 0 | — | 0 | 34 |
| 2014 | 0 | — | 0 | 24 |
| 2015 | 0 | — | 0 | 29 |
| 2016 | 0 | — | 0 | 20 |
| 2017 | 0 | — | 0 | 28 |
| 2018 | 0 | — | 0 | 15 |
| 2019 | 0 | — | 0 | 28 |
| 2020 | 0 | — | 0 | 24 |
| 2021 | 0 | — | 1 | 34 |
| 2022 | 0 | — | 1 | 21 |
| 2023 | 0 | — | 0 | 16 |
| 2024 | 0 | — | 0 | 10 |
| 2025 | 0 | — | 0 | 27 |
| 2026 | 0 | — | 0 | — |
https://510kreport.com/device/P890045 · printed Nov 4, 2026
Cite this page
510(k) Report. “P890045: Gelseal TM Triaxial Vascular Graft.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P890045
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026